Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Showing results for diindolylmethane breast cancer. Your search for diindolemethane breast cancer retrieved no results.

Results: 1 to 20 of 77

1.

Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.

Marques M, Laflamme L, Benassou I, Cissokho C, Guillemette B, Gaudreau L.

BMC Cancer. 2014 Jul 21;14:524. doi: 10.1186/1471-2407-14-524.

PMID:
25048790
[PubMed - in process]
Free Article
2.

BRCA1 mRNA levels following a 4-6-week intervention with oral 3,3'-diindolylmethane.

Kotsopoulos J, Zhang S, Akbari M, Salmena L, Llacuachaqui M, Zeligs M, Sun P, Narod SA.

Br J Cancer. 2014 Jul 15. doi: 10.1038/bjc.2014.391. [Epub ahead of print]

PMID:
25025957
[PubMed - as supplied by publisher]
3.

Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

Paltsev M, Kiselev V, Muyzhnek E, Drukh V, Kuznetsov I, Pchelintseva O.

EPMA J. 2013 Dec 10;4(1):25. doi: 10.1186/1878-5085-4-25.

PMID:
24325835
[PubMed]
Free PMC Article
4.

DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism.

Fan S, Meng Q, Xu J, Jiao Y, Zhao L, Zhang X, Sarkar FH, Brown ML, Dritschilo A, Rosen EM.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18650-5. doi: 10.1073/pnas.1308206110. Epub 2013 Oct 14.

PMID:
24127581
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

3,3'-diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells.

Nicastro HL, Firestone GL, Bjeldanes LF.

J Nutr Biochem. 2013 Nov;24(11):1882-8. doi: 10.1016/j.jnutbio.2013.05.004. Epub 2013 Aug 19.

PMID:
23968581
[PubMed - indexed for MEDLINE]
6.

Epigenetic modifications of Nrf2 by 3,3'-diindolylmethane in vitro in TRAMP C1 cell line and in vivo TRAMP prostate tumors.

Wu TY, Khor TO, Su ZY, Saw CL, Shu L, Cheung KL, Huang Y, Yu S, Kong AN.

AAPS J. 2013 Jul;15(3):864-74. doi: 10.1208/s12248-013-9493-3. Epub 2013 May 9.

PMID:
23658110
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.

Lo R, Matthews J.

Toxicol Appl Pharmacol. 2013 Jul 15;270(2):139-48. doi: 10.1016/j.taap.2013.03.029. Epub 2013 Apr 11.

PMID:
23583297
[PubMed - indexed for MEDLINE]
8.

2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway.

Bhowmik A, Das N, Pal U, Mandal M, Bhattacharya S, Sarkar M, Jaisankar P, Maiti NC, Ghosh MK.

PLoS One. 2013;8(3):e59798. doi: 10.1371/journal.pone.0059798. Epub 2013 Mar 28.

PMID:
23555785
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

3,3'-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway.

Yao Z, Hu W, Yin S, Huang Z, Zhu Q, Chen J, Zang Y, Dong L, Zhang J.

Pharmacol Res. 2013 Apr;70(1):139-46. doi: 10.1016/j.phrs.2013.01.006. Epub 2013 Jan 31.

PMID:
23376355
[PubMed - indexed for MEDLINE]
10.

3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells.

Ahmad A, Ali S, Ahmed A, Ali AS, Raz A, Sakr WA, Rahman KM.

PLoS One. 2013;8(1):e54657. doi: 10.1371/journal.pone.0054657. Epub 2013 Jan 22.

PMID:
23372748
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Indole compounds against breast cancer: recent developments.

Biersack B, Schobert R.

Curr Drug Targets. 2012 Dec;13(14):1705-19. Review.

PMID:
23140282
[PubMed - indexed for MEDLINE]
12.

Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3'-diindolylmethene in human breast epithelial cell lines.

Licznerska BE, Szaefer H, Murias M, Bartoszek A, Baer-Dubowska W.

Eur J Nutr. 2013 Aug;52(5):1483-92. doi: 10.1007/s00394-012-0455-9. Epub 2012 Oct 23. Erratum in: Eur J Nutr. 2014 Apr;53(3):995.

PMID:
23090135
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer.

Jiang J, Thyagarajan-Sahu A, Loganathan J, Eliaz I, Terry C, Sandusky GE, Sliva D.

Oncol Rep. 2012 Oct;28(4):1139-45. doi: 10.3892/or.2012.1936. Epub 2012 Jul 26.

PMID:
22842551
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines.

Szaefer H, Licznerska B, Krajka-Kuźniak V, Bartoszek A, Baer-Dubowska W.

Nutr Cancer. 2012 Aug;64(6):879-88. doi: 10.1080/01635581.2012.690928. Epub 2012 Jun 20.

PMID:
22716309
[PubMed - indexed for MEDLINE]
15.

Molecular target based combinational therapeutic approaches in thyroid cancer.

Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK.

J Transl Med. 2012 May 1;10:81. doi: 10.1186/1479-5876-10-81.

PMID:
22548798
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Inhibition of fatty acid synthase and Sp1 expression by 3,3'-diindolylmethane in human breast cancer cells.

Saati GE, Archer MC.

Nutr Cancer. 2011;63(5):790-4. doi: 10.1080/01635581.2011.570896. Epub 2011 Jun 22.

PMID:
21767081
[PubMed - indexed for MEDLINE]
17.

3,3'-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation.

Jin Y.

Mol Cell Biochem. 2011 Dec;358(1-2):345-54. doi: 10.1007/s11010-011-0985-0. Epub 2011 Jul 15.

PMID:
21761201
[PubMed - indexed for MEDLINE]
18.

3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cells: retraction.

[No authors listed]

Anticancer Drugs. 2011 Mar;22(3):303. doi: 10.1097/CAD.0b013e328344b81f. No abstract available.

PMID:
21282984
[PubMed - indexed for MEDLINE]
19.

3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.

Ahmad A, Ali S, Wang Z, Ali AS, Sethi S, Sakr WA, Raz A, Rahman KM.

Int J Cancer. 2011 Oct 1;129(7):1781-91. doi: 10.1002/ijc.25839. Epub 2011 Mar 8.

PMID:
21154750
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

3,3'-Diindolylmethane decreases VCAM-1 expression and alleviates experimental colitis via a BRCA1-dependent antioxidant pathway.

Huang Z, Zuo L, Zhang Z, Liu J, Chen J, Dong L, Zhang J.

Free Radic Biol Med. 2011 Jan 15;50(2):228-36. doi: 10.1016/j.freeradbiomed.2010.10.703. Epub 2010 Oct 26.

PMID:
21034812
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk